LERACERE Trademark

Trademark Overview


On Wednesday, July 24, 2013, a trademark application was filed for LERACERE with the United States Patent and Trademark Office. The USPTO has given the LERACERE trademark a serial number of 86019101. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2017. This trademark is owned by Eli Lilly and Company. The LERACERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic prepara...
leracere

General Information


Serial Number86019101
Word MarkLERACERE
Filing DateWednesday, July 24, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, March 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 22, 2016EXTENSION 5 GRANTED
Thursday, June 30, 2016EXTENSION 5 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Saturday, January 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 22, 2016EXTENSION 4 GRANTED
Wednesday, December 9, 2015EXTENSION 4 FILED
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Wednesday, July 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 21, 2015EXTENSION 3 GRANTED
Thursday, July 16, 2015EXTENSION 3 FILED
Thursday, July 16, 2015TEAS EXTENSION RECEIVED
Tuesday, December 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 22, 2014EXTENSION 2 GRANTED
Monday, December 8, 2014EXTENSION 2 FILED
Monday, December 8, 2014TEAS EXTENSION RECEIVED
Tuesday, August 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 4, 2014EXTENSION 1 GRANTED
Monday, July 7, 2014EXTENSION 1 FILED
Monday, August 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 7, 2014TEAS EXTENSION RECEIVED
Tuesday, February 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2013ASSIGNED TO EXAMINER
Tuesday, July 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 27, 2013NEW APPLICATION ENTERED IN TRAM